Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3064756 | Journal of Neuroimmunology | 2010 | 4 Pages |
Abstract
The reason why EBV-specific cellular immune responses are abnormal in multiple sclerosis (MS) patients is still missing. In this exploratory pilot study, we assessed IL-1β, IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, TGF-β1 and FOXP3 mRNA expression in EBV-stimulated highly differentiated T cells (THD) of MS patients and healthy controls (HC). We found increased levels of IFN-γ and IL-4 mRNA in CD8+ THD cells of MS patients. All the other tested molecules were expressed similarly in MS patients and HC. Interestingly, increased IFN-γ and IL-4 suggest that the control of EBV replication may be insufficient in MS patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Emilie Jaquiéry, Samantha Jilek, Myriam Schluep, Géraldine Le Goff, Miguel Garcia, Giuseppe Pantaleo, Renaud A. Du Pasquier,